Siguret V - Search Results

1

Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression.

Lavergne JM, Piao Y, Ribba AS, Girma JP, Siguret V, Piétu G, Boyer-Neumann C, Schandelong A, Bahnak BR, Meyer D. Lavergne JM, et al. Among authors: siguret v. Thromb Haemost. 1993 Oct 18;70(4):691-6. Thromb Haemost. 1993. PMID: 8115998

2

Identification of a CpG mutation in the coagulation factor-IX gene by analysis of amplified DNA sequences.

Siguret V, Amselem S, Vidaud M, Assouline Z, Kerbiriou-Nabias D, Piétu G, Goossens M, Larrieu MJ, Bahnak B, Meyer D, et al. Siguret V, et al. Br J Haematol. 1988 Dec;70(4):411-6. doi: 10.1111/j.1365-2141.1988.tb02509.x. Br J Haematol. 1988. PMID: 3219291

3

A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.

Siguret V, Lavergne JM, Chérel G, Boyer-Neumann C, Ribba AS, Bahnak BR, Meyer D, Piétu G. Siguret V, et al. Hum Genet. 1994 Feb;93(2):95-102. doi: 10.1007/BF00210590. Hum Genet. 1994. PMID: 7906671

4

Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.

Piétu G, Ribba AS, Chérel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D. Piétu G, et al. Among authors: siguret v. Thromb Haemost. 1994 Jun;71(6):788-92. Thromb Haemost. 1994. PMID: 7974349

5

Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene.

Vidaud D, Vidaud M, Bahnak BR, Siguret V, Gispert Sanchez S, Laurian Y, Meyer D, Goossens M, Lavergne JM. Vidaud D, et al. Among authors: siguret v. Eur J Hum Genet. 1993;1(1):30-6. doi: 10.1159/000472385. Eur J Hum Genet. 1993. PMID: 8069649

6

Effect of plasmid size on transformation efficiency by electroporation of Escherichia coli DH5 alpha.

Siguret V, Ribba AS, Chérel G, Meyer D, Piétu G. Siguret V, et al. Biotechniques. 1994 Mar;16(3):422-6. Biotechniques. 1994. PMID: 8185915 No abstract available.

7

Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease.

Ribba AS, Christophe O, Derlon A, Cherel G, Siguret V, Lavergne JM, Girma JP, Meyer D, Pietu G. Ribba AS, et al. Among authors: siguret v. Blood. 1994 Feb 1;83(3):833-41. Blood. 1994. PMID: 8298143 Free article.

8

Characterization of recombinant von Willebrand factors mutated on cysteine 509 or 695.

Siguret V, Ribba AS, Christophe O, Chérel G, Obert B, Rouault C, Nishikubo T, Meyer D, Girma JP, Piétu G. Siguret V, et al. Thromb Haemost. 1996 Sep;76(3):453-9. Thromb Haemost. 1996. PMID: 8883286

9

[Biological diagnosis of Willebrand disease].

Siguret V, Ribba AS, Meyer D. Siguret V, et al. Ann Biol Clin (Paris). 1997 Nov-Dec;55(6):601-6. Ann Biol Clin (Paris). 1997. PMID: 9499922 Free article. French. No abstract available.

10

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin.

Gouin-Thibault I, Delavenne X, Blanchard A, Siguret V, Salem JE, Narjoz C, Gaussem P, Beaune P, Funck-Brentano C, Azizi M, Mismetti P, Loriot MA. Gouin-Thibault I, et al. Among authors: siguret v. J Thromb Haemost. 2017 Feb;15(2):273-283. doi: 10.1111/jth.13577. Epub 2017 Feb 6. J Thromb Haemost. 2017. PMID: 27893182 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page